View in EDS HTML Full Text PDF Full Text

Real-World Benefit of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Findings from a Systematic Literature Review and Meta-Analysis.

Saved in:
Bibliographic Details
Title: Real-World Benefit of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: Findings from a Systematic Literature Review and Meta-Analysis.
Authors: Gottlieb, Scott1 (AUTHOR), Farberg, Aaron S.2,3 (AUTHOR), Bhatia, Neal4 (AUTHOR), Fazeli, Mir Sohail5 (AUTHOR), Hofer, Kimberly5 (AUTHOR), Lam, Otto5 (AUTHOR), Barghout, Victoria6 (AUTHOR), Mathew, Jacob7 (AUTHOR) Jacob.Mathew@sunpharma.com, Ferro, Thomas J.7 (AUTHOR)
Source: Dermatology & Therapy. Feb2026, Vol. 16 Issue 2, p911-936. 26p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-025-01625-6